Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Quick Stats
Apr 02, 202664.2
AI Score
BUY0.82
Volume Ratio
May 07, 2026
Next Earnings
10
+ve Days (30d)
11
-ve Days (30d)
FOLD Stock Summary
Last updated Apr 02, 2026
FOLD is currently trading at $14.44, positioned above its 200-day moving average of $10.2, indicating a long-term uptrend. The stock has a 52-week range of $5.51 to $14.46.
Technical Analysis: The 50-day moving average stands at $14.35, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.636, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.155, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates FOLD at 64.2/100 with a BUY recommendation.
FOLD (Amicus Therapeutics, Inc) Indicators
Last updated Apr 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.636 |
| CMF (20) | 0.155 |
| ROC (10) | 0.417 |
| ADX (14) | 52.413 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.028 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -22.222 |
| MFI (14) | 60.632 |
FOLD Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
FOLD Price vs Max Options Open Interest
FOLD Max Change In Options Open Interest
FOLD Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Daily Out of Money Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Daily In the Money Options - Sort by Max open Interest (near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Most Active Options by Volume(near term)
3rd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Amicus Therapeutics, Inc is above both 50 Day and 200 Day SMA which is considered Bullish.
FOLD Moving Averages Analysis
Amicus Therapeutics, Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 02, 2026
Amicus Therapeutics, Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 02, 2026
FOLD (Amicus Therapeutics, Inc) Simple Moving Averages
Moving Averages are last updated Apr 02, 2026
| Days | MA |
|---|---|
| 10 | 14.43 |
| 20 | 14.4 |
| 30 | 14.38 |
| 50 | 14.35 |
| 100 | 13.03 |
| 200 | 10.2 |
FOLD Fundamental Analysis
| P/E (Forward) | 30.4878 |
| P/E (Trailing) | -- |
| Market Cap ($) | 4.5 billion |
| Earnings/Share ($) | -0.09 |
| Net Proft Margin (%) | -0.0428 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.6467 |
| EPS Estimate Next Year ($) | 0.9182 |
| WallStreet Target Price ($) | 14.5 |
| Most Recent Quarter |